[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:hdv-rna":3},{"name":4,"total":5,"recruiting":6,"trials":7},"HDV RNA",2,1,[8,16],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07096193","Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus",[12],"Phase 1\u002FPhase 2","RECRUITING","2026-08-26T02:17:02.694423Z","2026-06-17T02:29:30.010819Z",{"nct_id":17,"title":18,"phases":19,"status":21,"updated_at":22,"content_modified":23},"NCT07298330","A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)",[20],"Phase 3","ACTIVE_NOT_RECRUITING","2026-08-03T02:16:24.793466Z","2026-05-05T02:43:27.661713Z"]